Merck & Co Inc (MRK)

101.52 +1.66 (+1.66%) USD  |  NYSE  |  Nov 22, 11:47
More

Merck Research and Development Expense (Quarterly): 5.862B for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 1994. Upgrade now.
Date Value
September 30, 2024 5.862B
June 30, 2024 3.50B
March 31, 2024 3.992B
December 31, 2023 9.627B
September 30, 2023 3.307B
June 30, 2023 13.32B
March 31, 2023 4.276B
December 31, 2022 3.775B
September 30, 2022 4.399B
June 30, 2022 2.798B
March 31, 2022 2.576B
December 31, 2021 3.068B
September 30, 2021 2.445B
June 30, 2021 4.321B
March 31, 2021 2.412B
December 31, 2020 5.788B
September 30, 2020 3.349B
June 30, 2020 2.085B
March 31, 2020 2.209B
December 31, 2019 2.40B
September 30, 2019 3.204B
June 30, 2019 2.189B
March 31, 2019 1.931B
December 31, 2018 2.214B
September 30, 2018 2.068B
Date Value
June 30, 2018 2.274B
March 31, 2018 3.196B
December 31, 2017 2.315B
September 30, 2017 4.413B
June 30, 2017 1.782B
March 31, 2017 1.83B
December 31, 2016 4.786B
September 30, 2016 1.664B
June 30, 2016 2.151B
March 31, 2016 1.659B
December 31, 2015 1.798B
September 30, 2015 1.50B
June 30, 2015 1.67B
March 31, 2015 1.737B
December 31, 2014 2.283B
September 30, 2014 1.659B
June 30, 2014 1.664B
March 31, 2014 1.574B
December 31, 2013 1.835B
September 30, 2013 1.66B
June 30, 2013 2.101B
March 31, 2013 1.907B
December 31, 2012 2.224B
September 30, 2012 1.918B
June 30, 2012 2.165B

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

2.085B
Minimum
Jun 2020
13.32B
Maximum
Jun 2023
4.276B
Average
3.424B
Median

Research and Development Expense (Quarterly) Benchmarks

Amgen Inc 1.45B
Johnson & Johnson 4.952B
Eli Lilly and Co 2.734B
Pfizer Inc 2.598B
Moderna Inc 1.137B